# A Clinical Study to Assess the Safety and Effectiveness of Scalp Cream for Symptom Relief and Microbiome Balance in Mild-moderate Seborrheic Dermatitis Patients.

> **NCT07063615** · NA · ACTIVE_NOT_RECRUITING · sponsor: **NovoBliss Research Pvt Ltd** · enrollment: 34 (estimated)

## Conditions studied

- Seborrheic Dermatitis

## Interventions

- **OTHER:** Microbiome-Powered Cream
- **OTHER:** Placebo Hair Cream

## Key facts

- **NCT ID:** NCT07063615
- **Lead sponsor:** NovoBliss Research Pvt Ltd
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-21
- **Primary completion:** 2026-02-09
- **Final completion:** 2026-02-09
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07063615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07063615, "A Clinical Study to Assess the Safety and Effectiveness of Scalp Cream for Symptom Relief and Microbiome Balance in Mild-moderate Seborrheic Dermatitis Patients.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07063615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
